Evidence map›Paper›PMID 25789523›Full record

ArticleClinics (Sao Paulo, Brazil)2015

Trypsin inhibitor from tamarindus indica L. seeds reduces weight gain and food consumption and increases plasmatic cholecystokinin levels.

Joycellane Alline do Nascimento Campos Ribeiro, Alexandre Coellho Serquiz, Priscila Fabíola dos Santos Silva, Patrícia Batista Barra Medeiros Barbosa, Tarcísio Bruno Montenegro Sampaio, Raimundo Fernandes de Araújo Junior, Adeliana Silva de Oliveira, Richele Janaina Araújo Machado, Bruna Leal Lima Maciel, Adriana Ferreira Uchôa and 2 more

Open access · goldAbstract read
In one paragraph

Article in Clinics (Sao Paulo, Brazil), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. ProspectingJournal of enzyme inhibition and medicinal chemistry · 2023
    Article
  7. Encapsulated Peptides and Proteins with an Effect on Satiety.Nanomaterials (Basel, Switzerland) · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Joycellane Alline do Nascimento Campos RibeiroDepartment of Biochemistry, Biosciences Center, Federal University of Rio Grande do Norte, Natal, RN, Brazil.
Alexandre Coellho SerquizDepartment of Biochemistry, Biosciences Center, Federal University of Rio Grande do Norte, Natal, RN, Brazil.
Priscila Fabíola dos Santos SilvaDepartment of Nutrition, Rio Grande do Norte, Center for Health Sciences, Federal University of Rio Grande do Norte, RN;Natal, Brazil.
Patrícia Batista Barra Medeiros BarbosaDepartment of Biochemistry, Biosciences Center, Federal University of Rio Grande do Norte, Natal, RN, Brazil.
Tarcísio Bruno Montenegro SampaioBiology Course, Potiguar University, RN;Natal, Brazil.
Raimundo Fernandes de Araújo JuniorDepartment of Morfology, Center for Biosciences, Federal University of Rio Grande do Norte, Natal/RN;RN, Brazil.
Adeliana Silva de OliveiraDepartment of Biochemistry, Biosciences Center, Federal University of Rio Grande do Norte, Natal, RN, Brazil.
Richele Janaina Araújo MachadoDepartment of Biochemistry, Biosciences Center, Federal University of Rio Grande do Norte, Natal, RN, Brazil.
Bruna Leal Lima MacielDepartment of Nutrition, Rio Grande do Norte, Center for Health Sciences, Federal University of Rio Grande do Norte, RN;Natal, Brazil.
Adriana Ferreira UchôaDepartment of Cell Biology and Genetics, Center for Biosciences, Federal University of Rio Grande do Norte, RN;Natal, Brazil.
Elizeu Antunes dos SantosDepartment of Biochemistry, Biosciences Center, Federal University of Rio Grande do Norte, Natal, RN, Brazil.
Ana Heloneida de Araújo MoraisDepartment of Nutrition, Rio Grande do Norte, Center for Health Sciences, Federal University of Rio Grande do Norte, RN;Natal, Brazil.
Universidade Federal do Rio Grande do Norte · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesSeeds are excellent sources of proteinase inhibitors, some of which may have satietogenic and slimming actions. We evaluated the effect of a trypsin inhibitor from Tamarindus indica L. seeds on weight gain, food consumption and cholecystokinin levels in Wistar rats.

methodsA trypsin inhibitor from Tamarindus was isolated using ammonium sulfate (30-60%) following precipitation with acetone and was further isolated with Trypsin-Sepharose affinity chromatography. Analyses were conducted to assess the in vivo digestibility, food intake, body weight evolution and cholecystokinin levels in Wistar rats. Histological analyses of organs and biochemical analyses of sera were performed.

resultsThe trypsin inhibitor from Tamarindus reduced food consumption, thereby reducing weight gain. The in vivo true digestibility was not significantly different between the control and Tamarindus trypsin inhibitor-treated groups. The trypsin inhibitor from Tamarindus did not cause alterations in biochemical parameters or liver, stomach, intestine or pancreas histology. Rats treated with the trypsin inhibitor showed significantly elevated cholecystokinin levels compared with animals receiving casein or water.

conclusionThe results indicate that the isolated trypsin inhibitor from Tamarindus reduces weight gain by reducing food consumption, an effect that may be mediated by increased cholecystokinin. Thus, the potential use of this trypsin inhibitor in obesity prevention and/or treatment should be evaluated.

Indexed as

AnimalsBody WeightCholecystokininDigestionEatingGastrointestinal TractMaleModels, AnimalObesityPhytotherapyPlant ExtractsRats, WistarSatiationSeedsTamarindusTrypsin InhibitorsCholecystokininPlant ExtractsTrypsin Inhibitors

Identifiers

PMID25789523
PMCPMC4351314
OpenAlexW2087512792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.